| A2M |
Homo sapiens |
|
A2M is differentially expressed in 92 experiments [119 up/115 dn]: 26 organism parts: bone marrow [1 up/2 dn], lung [2 up/1 dn], ...; 30 disease states: normal [7 up/4 dn], breast cancer [0 up/2 dn], ...; 46 cell types, 36 cell lines, 15 compound treatments and 18 other conditions. |
| A2M, CPAMD5, FWP007 |
|
A2m (Mus musculus)
Mcr (Drosophila melanogaster)
A2MG_RAT (Rattus norvegicus)
(Compare orthologs)
|
|
|
| A-macroglobulin complement component, Alpha-2-macroglobulin, N-terminal, Alpha-2-macroglobulin, N-terminal 2, Alpha-macroglobulin, receptor-binding, TonB box, conserved site |
|
|
| Alzheimer disease, susceptibility to, Emphysema due to alpha-2-macroglobulin deficiency |
|
|
| acute-phase response, enzyme binding, extracellular space, interleukin-8 binding, platelet alpha granule lumen |
|
|
|
P01023
Q9BQ22
|
|
|
|
ENSG00000175899
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Monocyte
|
Cell type |
|
|
None
|
Compound treatment |
|
|
Stromal cell
|
Cell type |
|
|
Epithelial cell
|
Cell type |
|
|
Bone marrow
|
Organism part |
|
|
Lung
|
Organism part |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
PC3
|
Cell line |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
Macrophage
|
Cell type |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Cystic change
|
Histology |
|
|
HeLa
|
Cell line |
|
|
MK886
|
Compound treatment |
|
|
Breast cancer
|
Disease state |
|
|
Fibroblast
|
Cell type |
|
|
Cervical cancer
|
Disease state |
|
|
Primary gastric tumor
|
Organism part |
|
|
SKMEL5
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
Caudate nucleus
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Tumor
|
Organism part |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
MCF7
|
Cell line |
|
|
Uninfected
|
Infection |
|
|
Ist1
|
Cell line |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
HPL1
|
Cell line |
|
|
Lymphoid tissue
|
Organism part |
|
|
T47D
|
Cell line |
|
|
Native skin
|
Cell type |
|
|
Benign nevi
|
Disease state |
|
|
HaCaT
|
Cell line |
|
|
Arsenic oxide
|
Compound treatment |
|
|
Grade IV
|
Tumor grading |
|
|
Primary
|
Disease staging |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
T-cell acute lymphoblastic leu...
|
Disease state |
|
|
Glioblastoma
|
Disease state |
|
|
Granulocyte
|
Cell type |
|
|
CD34+
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
BT474
|
Cell line |
|
|
Astrocyte
|
Cell type |
|
|
YCC6
|
Cell line |
|
|
Epilepsy
|
Disease state |
|
|
R-(-)-apomorphine HCl
|
Compound treatment |
|
|
MCF10A
|
Cell line |
|
|
Smooth muscle
|
Organism part |
|
|
Whole blood
|
Organism part |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Lymph node
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Keratinocyte
|
Cell type |
|
|
Erythrocyte
|
Cell type |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Chondrocyte
|
Cell type |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
Gastric cancer
|
Disease state |
|
|
Duchenne muscular dystrophy
|
Disease state |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
ERbeta transfected
|
Genotype |
|
|
Tumor cell
|
Cell type |
|
|
SKBR3
|
Cell line |
|
|
Macaca mulatta
|
Organism |
|
|
ITV
|
Cell line |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Mononuclear cell
|
Cell type |
|
|
Seminiferous tubule
|
Organism part |
|
|
Breast carcinoma
|
Disease state |
|
|
Primary lymphatic endothelial ...
|
Cell type |
|
|
Pancreatic cancer
|
Disease state |
|
|
ITM-E6E7-ST
|
Cell line |
|
|
Rapamycin
|
Compound treatment |
|
|
Differentiated
|
Cell type |
|
|
Naive
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
Heart
|
Organism part |
|
|
Blood
|
Organism part |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Vasectomized
|
Clinical history |
|
|
T cell
|
Cell type |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
CD16+ dendritic cell
|
Cell type |
|
|
N/a
|
Test result |
|
|
STA ET1
|
Cell line |
|
|
CD4+ T-cell
|
Cell type |
|
|
Dendritic cell-derived interme...
|
Cell type |
|
|
Not applicable
|
Histology |
|
|
Fu97
|
Cell line |
|
|
ITM-E6E7
|
Cell line |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Obesity
|
Disease state |
|
|
Dendritic cell-derived osteocl...
|
Cell type |
|
|
ERalpha transfected
|
Genotype |
|
|
Pancreas
|
Organism part |
|
|
Conditioned mesenchymal stem c...
|
Cell type |
|
|
ITM-ST
|
Cell line |
|
|
Monocyte-derived osteoclast
|
Cell type |
|
|
ITM
|
Cell line |
|
|
M2 macrophage
|
Cell type |
|
|
Cartilage
|
Organism part |
|
|
Control
|
Phenotype |
|
|
Skeletal muscle
|
Organism part |
|
|
Secretory cell
|
Cell type |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Immortalized endothelial cell
|
Cell type |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
CD14+ monocyte
|
Cell type |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Senescence bypassed
|
Phenotype |
|
|
Testis
|
Organism part |
|
|
Metastatic
|
Disease staging |
|
|
Mercury dichloride
|
Compound treatment |
|
|
Leydig cell
|
Cell type |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Pancreatic ductal adenocarcino...
|
Disease state |
|
|
Phenol
|
Compound treatment |
|
|
Endothelial cell + pericyte
|
Cell type |
|
|
BDCA3+ dendritic cell
|
Cell type |
|
|
Pan troglodytes
|
Organism |
|
|
Skin substitute
|
Cell type |
|
|
Met5A
|
Cell line |
|
|
GLI60
|
Cell line |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
RM 82
|
Cell line |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Relapse 1; ER status ER+; brai...
|
Clinical info |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Astrocytoma
|
Disease state |
|
|
Female
|
Sex |
|
|
Male
|
Sex |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
HL-60
|
Cell line |
|
|
Multiple myeloma
|
Disease state |
|
|
Proliferative
|
Developmental stage |
|
|
Differentiated
|
Developmental stage |
|
|
Pleura
|
Organism part |
|
|
B-precursor acute lymphoblasti...
|
Disease state |
|
|
Neutrophil
|
Cell type |
|
|
Adipocyte
|
Cell type |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
BDCA1+ dendritic cell
|
Cell type |
|
|
MKN28
|
Cell line |
|
|
Chronic pancreatitis
|
Disease state |
|
|
P53 knockdown
|
RNAi |
|
|
SsMCF7
|
Cell line |
|
|
Germ cell
|
Cell type |
|
|
IL-4
|
Compound treatment |
|
|
Oligodendroglioma with 1p19q c...
|
Disease state |
|
|
HTERT transduced
|
Gene modification |
|
|
Ethanol
|
Compound treatment |
|
|
Ponasterone A
|
Compound treatment |
|
|
Pergolide methanesulfonate
|
Compound treatment |
|
|
Uterine cervix
|
Organism part |
|
|
Prostate
|
Organism part |
|
|
GLI56
|
Cell line |
|
|
Bladder mucosa
|
Organism part |
|
|
Bladder
|
Organism part |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
MKN7
|
Cell line |
|
|
Malignant pleural mesothelioma
|
Disease state |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
MS428
|
Cell line |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Chronic myelogenous leukemia
|
Disease state |
|
|
Presymptomatic
|
Disease staging |
|
|
Constipation-predominant
|
Clinical info |
|
|
RD-ES
|
Cell line |
|
|
|
|
|
Processing time: 0.143 secs.